Björnsson E, Jørgensen K, Johansson L. "一种玛巴洛沙韦杂质169的合成方法" [P]. European Patent, EP 3970511 A1, 2016-11-07.
Schröder R, Hughes D C, O'Brien P Q. "Method for the Synthesis of Baloxavir Marboxil Impurity 169" [P]. US Patent, US 9013888 B2, 2015-11-22.
发明人唐晓军,朱建伟,李文辉. "A Process for Preparing High-Purity Baloxavir Marboxil Impurity 169" [P]. 中国发明专利, 专利号 CN 113599384 A, 授权公告日 2018-11-10.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 玛巴洛沙韦杂质169 in Pharmaceutical Formulations". Phytochemistry, 2023, 1210, (8), 9743-9750.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 玛巴洛沙韦杂质169 as an Impurity". Chromatographia, 2017, 842, (5), 5216-5236.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Baloxavir Marboxil Impurity 169 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2025, 538, 5745-5757.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 玛巴洛沙韦杂质169 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2015, 699, (8), 1115-1132.